The Future of Powder Formulation Development

Isothermal Dry Particle Coating (iDPC)

Aston Particle Technologies are pioneers in providing innovative formulation solutions for small molecule and biological APIs through patented isothermal dry particle coating (iDPC) technology. 

Explore the technology
human body

Our integrated suite of applications connected with domain expertise in formulation development and in-house scale-up can offer support across pre-clinical processes to early phase I/II production

Why Choose Aston Particle Technologies?

APT has a well-seasoned industrial management team with decades of experience in large Pharma and Biotech companies. 

What We Do

  • Patented, low shear, and directly scalable iDPC technology does not use heat, solvents or any other mechanical mixing aids
  • Controllable and precise one-step micro/nano particle layering for a wide range of API types
  • Holistic R&D capabilities with comprehensive characterisation services
  • Quality by Design risk-based approach where iDPC only uses 3 critical process parameters
  • Manufacturing support up to 10 kg/h
  • In-house formulation development and technical troubleshooting for inhalational, biological and oral solid dose medicines
  • Cost-effective, environment friendly and reliable just-in time manufacturing capabilities

What We Offer

  • Formulation and Process Development
  • Analytical and Material Characterisation
  • Directly Scalable Manufacturing
Learn More About Partnering

News and Updates